These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 932430)

  • 21. Reaction of an activated complex of guinea-pig complement components, C56, with unsensitized erythrocytes and with erythrocytes carrying C3b molecule.
    Tamura N; Baba AS
    Immunology; 1976 Jul; 31(1):151-8. PubMed ID: 1027719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of lymphocyte blastogenesis by C3c and C3d.
    Schenkein HA; Genco RJ
    J Immunol; 1979 Mar; 122(3):1126-33. PubMed ID: 312817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Third component of complement (C3): structural properties in relation to functions.
    Bokisch VA; Dierich MP; Mūller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):1989-93. PubMed ID: 1056006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.
    Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1981 Jun; 153(6):1592-603. PubMed ID: 7252421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of low-molecular-weight products following reaction of C3-C3b with C3b inactivator and with trypsin.
    Freedman J; Chaplin H; Johnson CA; Hughes-Jones NC
    Vox Sang; 1977 Oct; 33(4):212-20. PubMed ID: 70885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of fibronectin with complement component C3.
    Hautanen A; Keski-Oja J
    Scand J Immunol; 1983 Mar; 17(3):225-30. PubMed ID: 6402811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of the breakdown of the third component of human complement (C3).
    Fontaine M; Rivat C
    Ann Immunol (Paris); 1979; 130C(3):349-66. PubMed ID: 475341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH; Abramovitz AS; Mayer MM
    J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of guinea pig lymphocyte-derived chemotactic factor for fibroblasts.
    Postlethwaite AE; Kang AH
    J Immunol; 1980 Mar; 124(3):1462-6. PubMed ID: 7358987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C3b receptors in glomerular disease.
    Moran J; Colasanti G; Amos N; Peters DK
    Clin Exp Immunol; 1977 May; 28(2):212-7. PubMed ID: 406109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of complement activation by cobra venom factor on the migration of T and B lymphocytes into rat thoracic duct lymph.
    Spry CJ; Lane JT; Vyakarnam A
    Immunology; 1977 Jun; 32(6):947-54. PubMed ID: 301855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C3 cleavage products stimulate release of prostaglandins by human mononuclear phagocytes in vitro.
    Rutherford B; Schenkein HA
    J Immunol; 1983 Feb; 130(2):874-7. PubMed ID: 6848600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis.
    Berger M; Fleisher TA
    J Immunol; 1983 Mar; 130(3):1021-3. PubMed ID: 6600466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.
    Hatzfeld A; Fischer E; Levesque JP; Perrin R; Hatzfeld J; Kazatchkine MD
    J Immunol; 1988 Jan; 140(1):170-5. PubMed ID: 2826586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement (C3b) interaction with the human granulocyte receptor: correlation of binding of fluid-phase radiolabeled ligand with histaminase release.
    Melamed J; Arnaout MA; Colten HR
    J Immunol; 1982 May; 128(5):2313-8. PubMed ID: 6801135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human lymphocytes bear membrane receptors for C3b and C3d.
    Eden A; Miller GW; Nussenzweig V
    J Clin Invest; 1973 Dec; 52(12):3239-42. PubMed ID: 4543024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
    Ross GD; Lambris JD
    J Exp Med; 1982 Jan; 155(1):96-110. PubMed ID: 6915077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antigenic and molecular alterations of C3 in the fluid phase during an immune reaction in normal human serum. Demonstration of a new conversion product, C3x.
    Spitzer RE; Stitzel AE; Pauling VL; Davis NC; West CD
    J Exp Med; 1971 Sep; 134(3 Pt 1):656-80. PubMed ID: 15776568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latent lymphokines: isolation of guinea pig latent lymphocyte-derived chemotactic factor for monocytes. Its activation by trypsin and a soluble factor from macrophages.
    Postlethwaite AE; Kang AH
    J Immunol; 1979 Aug; 123(2):561-7. PubMed ID: 458146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.
    Lambris JD; Ross GD
    J Immunol; 1982 Jan; 128(1):186-9. PubMed ID: 7033372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.